Cohen R L, Xi X P, Crowley C W, Lucas B K, Levinson A D, Shuman M A
Cancer Research Institute, University of California-San Francisco 94143.
Blood. 1991 Jul 15;78(2):479-87.
The goal of the present study was to assess the relative importance of receptor-bound and secreted plasminogen activator urokinase (u-PA) in generating cell-surface plasmin and fostering destruction of normal tissue by tumor cells. We first showed that active site-inhibited u-PA could displace endogenous u-PA from the surface of the human colon adenocarcinoma cell line HCT 116. We then prepared expression vectors for u-PA and for a mutant molecule in which the codon for the active site serine residue was changed to encode alanine. Expression of non-functional mutant u-PA decreased the level of cell-bound active u-PA by more than 95% via a mechanism that involved competition for receptor sites. Decreased cell-surface u-PA activity was associated with a decrease in cell-bound plasmin activity to undetectable levels, suggesting that receptor-bound u-PA plays an important role in the generation of plasmin on the cell surface. Transfectants that secreted eightfold to 20-fold elevated levels of active wild-type u-PA showed approximately 50% increases in cell-associated u-PA and only twofold to fourfold increases in cell-associated plasmin, suggesting that the role of secreted u-PA in generating cell-surface plasmin activity was relatively minor. In parent cells and both types of transfectants there was a good correlation between the amount of plasmin bound to the tumor cell surface and the extent to which a basement membrane substrate was degraded. These studies show that receptor-bound u-PA provides an efficient mechanism for plasmin generation on the surface of tumor cells, which, in turn, contributes significantly to their degradative potential.
本研究的目的是评估受体结合型和分泌型纤溶酶原激活物尿激酶(u-PA)在产生细胞表面纤溶酶以及促进肿瘤细胞破坏正常组织方面的相对重要性。我们首先表明,活性位点被抑制的u-PA能够从人结肠腺癌细胞系HCT 116的表面置换内源性u-PA。然后,我们制备了u-PA和一种突变分子的表达载体,其中活性位点丝氨酸残基的密码子被改变以编码丙氨酸。无功能突变型u-PA的表达通过一种涉及受体位点竞争的机制,使细胞结合的活性u-PA水平降低了95%以上。细胞表面u-PA活性的降低与细胞结合的纤溶酶活性降低至无法检测的水平相关,这表明受体结合型u-PA在细胞表面纤溶酶的产生中起重要作用。分泌的活性野生型u-PA水平升高8至20倍的转染细胞显示,细胞相关的u-PA增加了约50%,而细胞相关的纤溶酶仅增加了2至4倍,这表明分泌型u-PA在产生细胞表面纤溶酶活性方面的作用相对较小。在亲本细胞和两种类型的转染细胞中,与肿瘤细胞表面结合的纤溶酶量与基底膜底物被降解的程度之间存在良好的相关性。这些研究表明,受体结合型u-PA为肿瘤细胞表面纤溶酶的产生提供了一种有效的机制,这反过来又对其降解潜能有显著贡献。